BioXcel Therapeutics Inc To Host BXCL701 Key Opinion Leader Day Transcript
' -
Okay. I think we're ready to get started. So good afternoon. Welcome, everyone, and thank you for attending our BioXcel Key Opinion Leader Day event, either in person or virtually because I know we have about 40 people dialed in at this point. So my name is Dr. Vince O'Neill. I am Head of R&D at OnkosXcel, and I will be moderating the proceedings today.
So just a reminder that we may make during discussions or indeed in the slide presentations, forward-looking statements, and these are subject to risks and uncertainty, subject to change depending on market conditions, et cetera.
So I'm very excited to say that today over the next 2 hours, we're really going to do a deep dive into BXCL701, actually for the first time. So I'm really excited about that. And talking about the signs behind the molecule and also talk about its potential in the clinic. So to help us do that, we've invited 3 distinguished academic guests to be with us today. Dr.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |